BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 59 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2022. The put-call ratio across all filers is 2.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,009 | -43.2% | 700 | 0.0% | 0.00% | – |
| Q2 2023 | $3,535 | +167.2% | 700 | 0.0% | 0.00% | – |
| Q1 2023 | $1,323 | +5.0% | 700 | 0.0% | 0.00% | – |
| Q4 2022 | $1,260 | +26.0% | 700 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 700 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 700 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -55.6% | 700 | -35.1% | 0.00% | – |
| Q3 2021 | $9,000 | 0.0% | 1,079 | +54.1% | 0.00% | – |
| Q2 2021 | $9,000 | -47.1% | 700 | 0.0% | 0.00% | – |
| Q1 2021 | $17,000 | -22.7% | 700 | 0.0% | 0.00% | – |
| Q4 2020 | $22,000 | +4.8% | 700 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | +23.5% | 700 | +75.0% | 0.00% | – |
| Q2 2020 | $17,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $104,289,000 | 4.42% |
| Boxer Capital, LLC | 2,014,858 | $60,909,000 | 2.10% |
| RA Capital Management | 2,589,904 | $78,293,000 | 1.43% |
| Artal Group S.A. | 1,521,517 | $45,995,000 | 1.12% |
| Ikarian Capital, LLC | 358,941 | $10,851,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $24,260,000 | 0.59% |
| Bellevue Group AG | 1,403,000 | $42,413,000 | 0.59% |
| Logos Global Management LP | 123,465 | $3,732,000 | 0.48% |
| Casdin Capital, LLC | 289,395 | $8,748,000 | 0.39% |
| HighVista Strategies LLC | 16,391 | $496,000 | 0.36% |